Nautilus Biotechnology, Inc. (NAUT)
2.25
+0.43
(+23.63%)
USD |
NASDAQ |
Oct 09, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Debt to Equity Ratio : 0.2122 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2122 |
| March 31, 2026 | 0.1999 |
| December 31, 2025 | 0.1912 |
| September 30, 2025 | 0.1596 |
| June 30, 2025 | 0.1556 |
| March 31, 2025 | 0.1509 |
| December 31, 2024 | 0.146 |
| September 30, 2024 | 0.1413 |
| June 30, 2024 | 0.1386 |
| March 31, 2024 | 0.1348 |
| December 31, 2023 | 0.1305 |
| September 30, 2023 | 0.1285 |
| June 30, 2023 | 0.1259 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.1228 |
| December 31, 2022 | 0.0963 |
| September 30, 2022 | 0.0897 |
| June 30, 2022 | 0.0877 |
| March 31, 2022 | 0.0859 |
| December 31, 2021 | 0.0826 |
| September 30, 2021 | 0.0095 |
| June 30, 2021 | 0.0018 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -3.808 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 4.767 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies, Inc. | 0.5363 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |
| Danaher Corp. | 0.5298 |
| Harvard Bioscience, Inc. | 5.959 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 163.58M |
| Total Liabilities (Quarterly) | 32.46M |
| Shareholders Equity (Quarterly) | 131.11M |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | 0.13% |